BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10477086)

  • 1. Intracisternal sauvagine is more potent than corticotropin-releasing factor to decrease gastric vagal efferent activity in rats.
    Kosoyan HP; Wei JY; Taché Y
    Peptides; 1999; 20(7):851-8. PubMed ID: 10477086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracisternal TRH and RX 77368 potently activate gastric vagal efferent discharge in rats.
    O-Lee TJ; Wei JY; Taché Y
    Peptides; 1997; 18(2):213-9. PubMed ID: 9149293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bombesin acts in the brain to decrease gastric vagal efferent discharge in rats.
    Yoshida-Yoneda E; Wei JY; Taché Y
    Peptides; 1993; 14(2):339-43. PubMed ID: 8483811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric vagal efferent inhibition evoked by intravenous CRF is unrelated to simultaneously recorded vagal afferent activity in urethane-anesthetized rats.
    Adelson DW; Kosoyan HP; Wang Y; Steinberg JZ; Taché Y
    J Neurophysiol; 2007 Apr; 97(4):3004-14. PubMed ID: 17314242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracisternal urocortin inhibits vagally stimulated gastric motility in rats: role of CRF(2).
    Chen CY; Million M; Adelson DW; Martínez V; Rivier J; Taché Y
    Br J Pharmacol; 2002 May; 136(2):237-47. PubMed ID: 12010772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary-adrenal and vagus modulation of sauvagine- and CRF-induced inhibition of gastric emptying in rats.
    Broccardo M; Improta G
    Eur J Pharmacol; 1990 Jul; 182(2):357-62. PubMed ID: 2397746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks peripheral CRF- and abdominal surgery-induced delayed gastric emptying in rats.
    Martínez V; Rivier J; Taché Y
    J Pharmacol Exp Ther; 1999 Aug; 290(2):629-34. PubMed ID: 10411571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral bombesin decreases gastric vagal efferent activity in part through vagal pathways in rats.
    Yoshida-Yoneda E; Taché Y; Kosoyan HP; Wei JY
    Am J Physiol; 1994 Jun; 266(6 Pt 2):R1868-75. PubMed ID: 8024041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks CRF- and stress-related alterations of gastric and colonic motor function.
    Martínez V; Rivier J; Wang L; Taché Y
    J Pharmacol Exp Ther; 1997 Feb; 280(2):754-60. PubMed ID: 9023288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CRF(1) receptor antagonist, NBI-35965, abolished the activation of locus coeruleus neurons induced by colorectal distension and intracisternal CRF in rats.
    Kosoyan HP; Grigoriadis DE; Taché Y
    Brain Res; 2005 Sep; 1056(1):85-96. PubMed ID: 16095571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urocortin 2 acts centrally to delay gastric emptying through sympathetic pathways while CRF and urocortin 1 inhibitory actions are vagal dependent in rats.
    Czimmer J; Million M; Taché Y
    Am J Physiol Gastrointest Liver Physiol; 2006 Mar; 290(3):G511-8. PubMed ID: 16223946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRF microinjected into the dorsal vagal complex inhibits TRH analog- and kainic acid-stimulated gastric contractility in rats.
    Heymann-Mönnikes I; Taché Y; Trauner M; Weiner H; Garrick T
    Brain Res; 1991 Jul; 554(1-2):139-44. PubMed ID: 1933296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central CRF inhibits gastric emptying of a nutrient solid meal in rats: the role of CRF2 receptors.
    Martinez V; Barquist E; Rivier J; Taché Y
    Am J Physiol; 1998 May; 274(5):G965-70. PubMed ID: 9612279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central nervous system action of corticotropin-releasing factor to inhibit gastric emptying in rats.
    Taché Y; Maeda-Hagiwara M; Turkelson CM
    Am J Physiol; 1987 Aug; 253(2 Pt 1):G241-5. PubMed ID: 3497585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 1 beta inhibits gastric emptying in rats: mediation through prostaglandin and corticotropin-releasing factor.
    Sütö G; Király A; Taché Y
    Gastroenterology; 1994 Jun; 106(6):1568-75. PubMed ID: 8194703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo analysis of the effects of corticotropin releasing factor on rat dorsal vagal complex.
    Lewis MW; Hermann GE; Rogers RC; Travagli RA
    J Physiol; 2002 Aug; 543(Pt 1):135-46. PubMed ID: 12181286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bombesin microinjected into the dorsal vagal complex inhibits TRH-stimulated gastric contractility in rats.
    Heymann-Mönnikes I; Livingston EH; Taché Y; Sierra A; Weiner H; Garrick T
    Brain Res; 1990 Nov; 533(2):309-14. PubMed ID: 2126976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasticity in the brainstem vagal circuits controlling gastric motor function triggered by corticotropin releasing factor.
    Browning KN; Babic T; Toti L; Holmes GM; Coleman FH; Travagli RA
    J Physiol; 2014 Oct; 592(20):4591-605. PubMed ID: 25128570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin-releasing factor acts centrally to suppress stimulated gastric contractility in the rat.
    Garrick T; Veiseh A; Sierra A; Weiner H; Taché Y
    Regul Pept; 1988 May; 21(1-2):173-81. PubMed ID: 3134672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central neuropeptide Y and the sigma ligand, JO 1784, reverse corticotropin-releasing factor-induced inhibition of gastric acid secretion in rats.
    Gué M; Yoneda M; Mönnikes H; Junien JL; Taché Y
    Br J Pharmacol; 1992 Nov; 107(3):642-7. PubMed ID: 1472962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.